Although some variation with anatomical location within the brain was seen, this study indicated that ZNT1 protein expression is increased in the pre-clinical and early stages of AD, and subsequently decreases in the late stages.38 These findings suggest that dysregulation of intracellular zinc signaling participates in AD development, but in a complex fashion. This evidence concerns the gene SLC30A1 and Alzheimer disease.